12 Month Price Forecast For LFWD
Distance to LFWD Price Forecasts
LFWD Price Momentum
๐ค Considering ReWalk (LFWD)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 16, 2025 4:48 AM UTC
LFWD Analyst Ratings & Price Targets
Based on our analysis of 3 Wall Street analysts, LFWD has a bullish consensus with a median price target of $10.00 (ranging from $6.00 to $13.00). The overall analyst rating is Strong Buy (8.7/10). Currently trading at $2.19, the median forecast implies a 357.7% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Swayampakula Ramakanth at HC Wainwright & Co., projecting a 495.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LFWD Analyst Consensus
LFWD Price Target Range
Latest LFWD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LFWD.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Feb 10, 2025 | Laidlaw & Co. | Yale Jen | Buy | Initiates | $10.00 |
Nov 13, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $13.00 |
Aug 16, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $13.00 |
May 16, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $13.00 |
Apr 15, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $9.00 |
Feb 28, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.00 |
Nov 15, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
Aug 14, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
Aug 10, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
Jul 3, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
May 12, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
Feb 24, 2023 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
Nov 15, 2022 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
Aug 10, 2022 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
Mar 1, 2021 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
Aug 13, 2020 | HC Wainwright & Co. | Buy | Maintains | $0.00 | |
Feb 21, 2020 | HC Wainwright & Co. | Buy | Reiterates | $0.00 | |
Jun 17, 2019 | HC Wainwright & Co. | Buy | Upgrade | $0.00 | |
Nov 3, 2017 | Jefferies | Buy | Maintains | $0.00 | |
Aug 4, 2017 | Canaccord Genuity | Buy | Maintains | $0.00 |
Stocks Similar to Lifeward Ltd.
The following stocks are similar to ReWalk based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Lifeward Ltd. (LFWD) Financial Data
Lifeward Ltd. has a market capitalization of $23.22M with a P/E ratio of -0.8x. The company generates $25.00M in trailing twelve-month revenue with a -77.2% profit margin.
Revenue growth is +39.2% quarter-over-quarter, while maintaining an operating margin of -51.8% and return on equity of -45.1%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Lifeward Ltd. (LFWD) Company Overview
About Lifeward Ltd.
Develops medical devices for rehabilitation and mobility.
Lifeward Ltd. generates revenue by designing, developing, and selling innovative medical devices aimed at improving mobility and wellness for individuals with physical and neurological conditions. The company markets its products directly to healthcare institutions and individuals, as well as through third-party distributors, ensuring a wide reach in both rehabilitation and personal use markets.
The company's product lineup includes advanced technologies such as the ReWalk exoskeletons and the AlterG Anti-Gravity System, catering to various rehabilitation needs. Lifeward Ltd. was formerly known as ReWalk Robotics Ltd. and has been incorporated since 2001, with its headquarters located in Yokneam Illit, Israel.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
108
CEO
Mr. Lawrence J. Jasinski BS, MBA
Country
Israel
IPO Year
2014
Website
golifeward.comLifeward Ltd. (LFWD) Latest News & Analysis
The Company has secured recent financing and believes it has adequate cash to achieve its objectives.
The company's strong cash position indicates financial stability and the ability to execute growth plans, potentially enhancing shareholder value and attracting investor interest.
Lifeward Ltd. (Nasdaq: LFWD) has canceled its Extraordinary General Meeting scheduled for January 13, 2025, and will present its proposals at a later meeting in 2025.
Cancellation of the shareholder meeting may indicate uncertainty or internal issues within Lifeward, potentially affecting stock performance and investor confidence.
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
1 month agoLifeward Ltd. (Nasdaq: LFWD) will issue 1,818,183 ordinary shares at $2.75 each in a registered direct offering, along with short-term warrants. Closing expected on January 8, 2025.
Lifeward Ltd. is raising capital through a direct offering and warrants, potentially impacting share dilution and investor sentiment around its growth prospects.
Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
1 month agoLifeward Ltd. (Nasdaq: LFWD) closed a registered direct offering of 1.82 million shares at $2.75 each, along with unregistered short-term warrants for the same number of shares.
Lifeward's capital raise via share offering and warrants can signal growth potential but may dilute existing shares. Investors should assess the impact on share value and company strategy.
Lifeward Ltd. has postponed its Extraordinary General Meeting of Shareholders to January 13, 2025. The record date remains November 20, 2024.
The postponement of Lifeward's shareholder meeting may signal potential uncertainty or issues within the company, impacting investor confidence and stock performance.
Semmelweis University in Hungary has secured government coverage for exoskeleton training, increasing access at more spinal cord injury centers.
Government coverage for exoskeleton training can boost demand in the healthcare sector, potentially increasing revenues for companies involved in rehabilitation technologies and attracting investment.
Frequently Asked Questions About LFWD Stock
What is Lifeward Ltd.'s (LFWD) stock forecast for 2025?
Based on our analysis of 3 Wall Street analysts, Lifeward Ltd. (LFWD) has a median price target of $10.00. The highest price target is $13.00 and the lowest is $6.00.
Is LFWD stock a good investment in 2025?
According to current analyst ratings, LFWD has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.19. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for LFWD stock?
Wall Street analysts predict LFWD stock could reach $10.00 in the next 12 months. This represents a 357.7% increase from the current price of $2.19. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Lifeward Ltd.'s business model?
Lifeward Ltd. generates revenue by designing, developing, and selling innovative medical devices aimed at improving mobility and wellness for individuals with physical and neurological conditions. The company markets its products directly to healthcare institutions and individuals, as well as through third-party distributors, ensuring a wide reach in both rehabilitation and personal use markets.
What is the highest forecasted price for LFWD Lifeward Ltd.?
The highest price target for LFWD is $13.00 from Swayampakula Ramakanth at HC Wainwright & Co., which represents a 495.0% increase from the current price of $2.19.
What is the lowest forecasted price for LFWD Lifeward Ltd.?
The lowest price target for LFWD is $6.00 from at , which represents a 174.6% increase from the current price of $2.19.
What is the overall LFWD consensus from analysts for Lifeward Ltd.?
The overall analyst consensus for LFWD is bullish. Out of 3 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $10.00.
How accurate are LFWD stock price projections?
Stock price projections, including those for Lifeward Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.